de la Sierra Alejandro
Hypertension Unit, Department of Internal Medicine, Hospital Mútua Terrassa, University of Barcelona, Barcelona, Spain.
Cardiol Ther. 2019 Dec;8(2):157-166. doi: 10.1007/s40119-019-0144-3. Epub 2019 Jul 30.
In November 2017, the American College of Cardiology and the American Heart Association released hypertension guidelines for the first time, replacing the Joint National Committee periodical reports, appearing from 1977 to 2003. In parallel, the European Society of Cardiology and the European Society of Hypertension updated their own recommendations with a new document released in August 2018. While both documents contain similar recommendations concerning several aspects of detection, prevention, and management of hypertension, they differ in some sensitive characteristics, which specifically affect diagnostic and therapeutic aspects. While the European guidelines do not substantially modify previous recommendations, the American proposals are clearly disruptive. Main examples include a new definition for hypertension, with a blood pressure threshold of 130/80 mmHg. Not only does it modify its prevalence, but also carries important changes in therapeutic aspects, including treatment initiation and blood pressure goals for treated patients. In this review, the main differences between American and European recommendations are highlighted, along with the arguments exposed by both groups of experts and their possible impact affecting clinical practice in hypertension management.
2017年11月,美国心脏病学会和美国心脏协会首次发布高血压指南,取代了1977年至2003年发布的美国国家联合委员会定期报告。与此同时,欧洲心脏病学会和欧洲高血压学会在2018年8月发布的一份新文件中更新了他们自己的建议。虽然两份文件在高血压的检测、预防和管理的几个方面都包含类似的建议,但它们在一些敏感特征上有所不同,这些特征特别影响诊断和治疗方面。欧洲指南没有实质性修改先前的建议,而美国的提议显然具有颠覆性。主要例子包括高血压的新定义,血压阈值为130/80 mmHg。这不仅改变了高血压的患病率,而且在治疗方面带来了重要变化,包括治疗的开始和治疗患者的血压目标。在这篇综述中,强调了美国和欧洲建议之间的主要差异,以及两组专家提出的论据及其对高血压管理临床实践可能产生的影响。